Market News / Story
PFE, LLY, MRK Stocks In Focus: Cantor Raises Price Targets On Pharma Behemoths, But Flags Growth Concerns For Pfizer
Stocktwits ·
Stocktwits reports: Shares of Pfizer (PFE), Eli Lilly (LLY) and Merck (MRK) were in focus on Thursday after Cantor Fitzgerald raised its price targets on all three pharmaceutical giants, citing upcoming drug trial results, earnings expectations and growth opportunities. At the time of writing, MRK and PFE shares edged lower in pre-market trading while LLY shares were largely unchanged. Pfizer Faces Growth Questions As Job Cuts Loom Cantor raised Pfizer’s price target to $28 from $27 and…
Related stories
Higher bond yields are raising the bar for stocks: Stan WongRead story summary
For much of this year, “higher for longer” was a warning. Now it is a market reality. With the U.S. 10-year Treasury yield above 5.25 per cent and touching a two-decade high, borrowing costs are becoming harder for markets to ignore. Bonds also compete more directly with equities for investor capital. The implications for equity valuations are significant. ...
VIEW SOURCE- China’s Growth Target Has Become a Trap for Xi
Read story summary
China’s latest effort to prop up its battered housing market and spur the economy is getting a poor reception. The measures are underwhelming and unlikely to achieve much beyond improving Beijing’s chances of meeting its already restrained growth ambitions. That is damning the initiative with faint praise. The deeper problem lies in how China measures ...
VIEW SOURCE